Investors

Cugene is a clinical-stage biotechnology company focused on developing and commercializing next-gen precision immunology and oncology medicines that harness specific immune cells to treat autoimmune disease and cancer. We are seeking strategic partners and investors to accelerate our pipeline advancement.

Investor inquiries: IR@cugene.com.